Skip to main content

This is a preprint.

It has not yet been peer reviewed by a journal.

The National Library of Medicine is running a pilot to include preprints that result from research funded by NIH in PMC and PubMed.

bioRxiv logoLink to bioRxiv
[Preprint]. 2024 Apr 19:2024.04.16.589814. [Version 1] doi: 10.1101/2024.04.16.589814

Massively parallel jumping assay decodes Alu retrotransposition activity

Navneet Matharu 1,2,^,*, Jingjing Zhao 1,2,^, Ajuni Sohota 1,2, Linbei Deng 1,2, Yan Hung 1,2, Zizheng Li 1, Jasmine Sims 1,2, Sawitree Rattanasopha 1,2, Josh Meyer 3, Lucia Carbone 3,4,5,6, Martin Kircher 7,8,*, Nadav Ahituv 1,2,*
PMCID: PMC11042287  PMID: 38659854

Abstract

The human genome contains millions of retrotransposons, several of which could become active due to somatic mutations having phenotypic consequences, including disease. However, it is not thoroughly understood how nucleotide changes in retrotransposons affect their jumping activity. Here, we developed a novel massively parallel jumping assay (MPJA) that can test the jumping potential of thousands of transposons en masse. We generated nucleotide variant library of selected four Alu retrotransposons containing 165,087 different haplotypes and tested them for their jumping ability using MPJA. We found 66,821 unique jumping haplotypes, allowing us to pinpoint domains and variants vital for transposition. Mapping these variants to the Alu-RNA secondary structure revealed stem-loop features that contribute to jumping potential. Combined, our work provides a novel high-throughput assay that assesses the ability of retrotransposons to jump and identifies nucleotide changes that have the potential to reactivate them in the human genome.

Introduction

An estimated 42% of mammalian genomes consist of retrotransposable elements that ‘copy and paste’ in genomes via RNA mediated transposition1. One of the most abundant classes of retrotransposons in mammalian genomes are ‘Alu’ elements that are derived from 7SL RNA. Alu elements belong to the class of ‘Short Interspersed Nuclear Elements’ (SINEs) that have an Alu-1 restriction endonuclease site derived from Arthrobacter Luteus bacteria. Alu elements are non-autonomous retrotransposons, as they need to hijack transposition machinery from other retrotransposons (i.e., LINES/LTRs) to jump. There are roughly 1.1 million Alu copies in the human genome2, which can be divided into three major subfamilies: 1) AluJ, the most ancient (~65 million years old, myo) and whose sequence is substantially degraded and thus believed to be inactive3; 2) AluS, estimated to be ~30 myo and has elements that are less diverged from the consensus sequence and believed to include some active elements in the human genome; 3) AluY, the youngest lineage (~10 myo) with almost all AluY elements thought to be active. The human genome is predicted to have 852 intact functional Alu elements with thousands of copies that could be competent to jump4 and it is estimated that a new Alu insertion happens in the human genome every 20 live births3. The jumping activity of Alu elements positively correlates with the length of their polyA tail5,6. Additionally, the presence of an intact 280 base pair (bp) core Alu sequence is thought to be essential for retrotransposition6.

Comprehensive sequence homology analysis of the 280bp core region of 89 Alu elements from the human genome revealed that at least 124 nucleotide positions are conserved in all Alu elements that were tested to be active in retrotransposition assays4. However, no exhaustive functional study has been performed to date to correlate Alu jumping activity with sequence alterations. A high-resolution sequence-based functional analysis of the 280bp Alu core sequence is challenging, mainly due to lack of high-throughput retrotransposition assays. An assay for measuring the jumping activity of individual Alu elements has been established, utilizing splicing during the jumping event to infer antibiotic resistance, but can only test one element at a time4. In addition, while there have been studies that retrieve libraries of polymorphic LINE1 retrotransposons from the genome, directed evolution retrotransposition assays for Alu elements are lacking7,8.

Here, we developed a massively parallel jumping assay (MPJA) that can test in parallel the ability of thousands of Alu elements to retrotranspose in human cells (Fig. 1). We used it to test the reactivation potential of three different inactive Alu elements and one active element. Using error prone PCR, we generated 165,087 different Alu haplotypes and tested their jumping ability in HeLa cells. We found 66,821 haplotypes that enabled jumping and used these results to characterize functional Alu domains and annotate variants that are vital for retrotransposition. We observed that even a single nucleotide change is sufficient to change the activity of an Alu element. Overlapping these jumping-associated variants with Alu-RNA secondary structure identified stem-loop features that contribute to retrotransposition potential. In summary, our results provide a novel technology that can test the jumping ability of thousands of sequences and identifies key domains, RNA secondary structures and variants that are vital for retrotransposition.

Figure 1: Massively parallel jumping assay.

Figure 1:

a, Schematic showing the random mutagenesis strategy to generate Alu variant libraries using error prone PCR. b, Retrotransposition assay and Alu integration into the genome with the help of L1 transposase machinery. The transposition vector contains RNAPolIII 7SL driving an Alu-Neo cassette that is spliced and complexed with the ORF2 transposase machinery from the helper plasmid. The Alu-Neo cassette gets reverse transcribed and integrates randomly into the genome allowing the neomycin resistance gene to be expressed through the RNAPolII SV40 promoter thus conferring G-418 sulphate resistant colonies. c, Retrotransposed Alu resurrection and retrieval from the genome and sequence library generation. Alu-Neo integrations were selected using neomycin specific and Alu specific primers that generate a 1kb PCR product if neomycin is spliced due to retrotransposition. Alu specific primers are then used to amplify the integrated Alus which are then processed for sequencing.

Results

Retrotransposition assay optimization

We developed a massively parallel jumping assay (MPJA), based on a previous assay for individual Alu transposition9. In this assay, the retrotransposition cassette includes an Alu transcript that is driven by a 7SL PolIII enhancer (Fig. 1b). The 3’ of the Alu transcript has a PolII driven SV40-Neomycin (Neo) cassette cargo in antisense orientation before a PolIII termination signal, i.e. polyT tract. Upon PolIII Alu transcription, the resulting RNA gets spliced, due to the presence of an autocatalytic intron that is independent of PolII splicing and engages with the L1-ORF2 transposon machinery, which is needed for its genomic integration. The integrated Alu copy loses 7SL and the PolIII polyA retains the PolII SV40-spliced Neo cassette, providing neomycin resistance for colonies that undergo a retrotransposition event, which can then be used for selection.

We first set out to standardize the retrotransposition assay, using AluYa5, a highly active Alu element9, as a positive control. A vector containing AluYa5 was co-transfected with L1-ORF2 into HeLa cells (Fig. 1b). These cells were re-plated once before starting G-418 selection 4–5 days post transfection. After three weeks of G-418 stable selection, sizable colonies were observed (Fig. 1b, Extended Data Fig. 1 showing colony assay). Of note, we also observed a small number of colonies in the negative control (non-L1ORF2), likely due to random integration of the AluYa5 plasmid. These random unspliced product integrations could be easily detected by PCR primers unique to the vector and thus can be readily excluded from further processing. All colonies, both from AluYa5 and negative control, were further processed for genomic DNA extraction to examine Alu transposition. Upon splicing, the amplicon should be 500bp shorter than the unspliced 1.5kb band, allowing to distinguish random integration events versus transposition events (Fig. 1c). We found AluYa5 colonies to have a 500bp shorter PCR product compared to zero colonies from the negative control (Extended Data Fig 2a). This jumping assay is therefore extremely robust in detecting Alu sequences that lead to retrotransposition.

Selection of Alu elements for MPJA

Having optimized the retrotransposition assay, we next set out to choose a library of Alu elements to be tested by MPJA. A previous study that assessed the jumping activity of various Alu families from the human genome found the AluJ family to be inactive and have a highly divergent 280bp core region, the AluS family to be moderately active, and the AluY family to be highly active, both having an intact 280bp core4. For our MPJA, we wanted to test what nucleotide changes are required to reactivate inactive Alu elements that have an intact 280bp core. We selected members of the AluS family, since AluS family of retrotransposons largely consists of inactive elements with intact 280bp core and less diverged from the consensus AluSx sequence that is tested to be active in the retrotransposition assay4. A previous study that assessed 26 full length AluS elements, found 21 to be inactive having low to zero activity4. Building on these results, we applied stringent filters of inactivity to the same subfamily, to select three AluS inactive candidates that have an intact 280bp core region and at least 95% sequence similarity with the consensus active AluSx sequence: AluS-6b, AluS-14b and AluS-h1.1 (Fig. 2a). To further validate that they are indeed inactive or have very low jumping potential, we tested them individually in our assay confirming their activity as previously shown in a retrotransposition assay4 (Extended Data Fig 3).

Figure 2: Alu selection and variants calling in the mutagenized library.

Figure 2:

a, Sequence similarity (percent sequence identity), the number of sequence differences and the relative jumping potential to AluYa5 (positive control element considered to have activity score of 1) for all four tested Alu sequences. b, Pie charts showing the percent of haplotypes detected in the Alu-Mut jumping libraries from total haplotypes detected in Alu-Mut plasmid libraries. c, Variant calling at each position across the 280bp full-length Alu sequence in the Alu-mutagenized jumping/plasmid library and haplotype calling depicting only significant high jumping and low jumping haplotypes beyond a cut-off of +/− 2.5 log2 fold-change (Log2FC). Significant jumping was defined via the DESeq2 package using a Wald-test p-value threshold of 10-5. Lowest panel shows a schematic depicting the major structural features in Alu-RNA.

Alu-MPJA saturation mutagenesis

We synthesized all four Alu sequences and cloned them into the Alu jumping vector followed by Sanger sequence validation. We then used an error-prone PCR system that is estimated to generate a mutation every 1-16bp per kilobase (kb) of DNA (see Methods) to generate roughly 1–6 mutations per 300bp Alu element10,11. The mutagenized PCR product of each Alu element was then re-cloned into the Alu jumping assay vector to generate four mutagenized libraries: AluSx-mut, Alu6b-mut, Alu14b-mut and Aluh1.1-mut (Supplementary Table 1). To assess their complexity, libraries were subjected to two rounds of massively parallel sequencing, finding both replicates to show a high degree of overlap and correlation in count representation of identical variants (Pearson and Spearman correlation coefficiencies, AluSx p-rho 1.00 s-rho 0.8; Alu6b p-rho 1.00 s-rho 0.72; Alu14b p-rho 1.00 s-rho 0.77; Aluh1.1 p-rho 1.00 s-rho 0.77; Extended Data Fig. 4 a). We found all four libraries to be highly saturated for single nucleotide variants (SNVs) with frequencies of transitions, transversion and indels at each position (Supplementary Table 2, Extended Data Fig. 5). On average, we detected 10 variants in each individual Alu sequence, due to a small subset of variants that were fixed in the early error prone PCR amplification, leading to a ‘founder effect’ (Extended Data Fig. 5).

We next performed the retrotransposition assay with all four Alu-Mut libraries. Libraries were transfected into HeLa cells which were then treated with G-418 three days post transfection. Following 3–4 weeks of G-418 selection, colonies were amplified and replated to achieve confluency and later subjected to genomic DNA extraction. Using specific PCR primers (Supplementary Table 3), we amplified all the Alu sequences from the genomic DNA that were retrotransposed. First, we specifically amplified the 1kb spliced Neo-Alu amplicon to differentiate from any plasmid integrations that could happen without retrotransposition, allowing to resurrect only transposed Alu elements from the genome (Extended Data Fig 2b). We also checked for primer set specificity of the Neo-Alu amplicon primers for any non-specific amplifications from the genomic DNA of un-transfected HeLa cells (Extended Data Fig 2c). Next, we used primer targeting the vector sequence on 3’ of the cloned Alu sequence and 5’ Alu specific primers to amplify 300 bp fragments containing 280bp Alu core sequence (Methods). We then generated a sequencing library from the resulting ~280bp band and indexed and pooled libraries in equimolar ratios for sequencing.

Alu-MPJA saturation mutagenesis analysis

We next analyzed the Alu-Mut library (the plasmid variant library) and Alu-jumping library (the library following retrotransposition) for each Alu element. We first obtained the total number of read counts for single nucleotide variants in each plasmid (Alu-Mut) and Alu-jumping library. We observed that most of the variants fall within the mismatch window of up to <10 nucleotides changes for all four Alu elements (Extended Data Fig. 6) in both Alu-Mut and Alu-jumping libraries. We then calculated log2 fold-change (log2FC) based on the frequency of reads from Alu-jumping vs Alu-Mut library. The significant variants with a positive fold-change and negative fold-change were determined using the DESeq2 R-package12 (Extended Data Fig. 5). We normalized fold-changes with the measured activity of the reference Alu sequence that we started our mutagenesis on to provide a ‘jumping score’ for the sequences (Fig 2a). We observed that highly enriched SNVs in the Alu-Mut plasmid library, either due to PCR bias or founder effect, were not necessarily enriched in the Alu-Mut jumping library, confirming that our measurements are focused on jumping activity (Fig. 2c).

Next, we compared results from the two Alu-Mut jumping technical replicates (Extended Data Fig. 4b), finding them to show good correlations (Pearson and Spearman correlation coefficients, AluSx p-rho 1.00 s-rho 0.59; Alu6b p-rho 0.95 s-rho 0.60; Alu14b p-rho 1.00 s-rho 0.54) except for Aluh1.1, which had a poor correlation between replicates (Aluh1.1 p-rho 0.44 s-rho 0.16) (Extended Data Fig. 4b). We thus decided to remove Aluh1.1 from all subsequent analysis. We also screened our Alu-Mut plasmid libraries for the possible phenomenon of index hopping reported earlier on Illumina sequencing platforms13. Despite using dual-indexing, which was reported previously to be able to address the inaccuracies of multiplexing, we did observe a low proportion of potential index-hopping (for AluSx 0.8%, Alu6b 2.3%, Alu14b 3%, total 2.2% in Alu-Mut plasmid libraries)14. We note that this might also be caused by spurious sharing of sequences or could be the result of cross-contamination before library prep, and we removed all these reads in our subsequent analysis.

We annotated Alu haplotypes, requiring a limit of up to 10 nucleotide changes per element, as we wanted to focus on the minimum number of sequence variants required to change the activity of the Alu element. In addition, we wanted to prioritize those haplotypes in line with the low rate of sequence variants created by the mutagenesis strategy that we adopted, which typically allows 1–16 base changes per kb according to the Genemorph mutagenesis kit (see Methods). We called a haplotype only if it had read counts higher than two in the plasmid library and greater than ten in the jumping library. In total, we annotated 20,733, 48,641 and 35,849 haplotypes in AluSx, Alu6b and Alu14b respectively in the plasmid library. Of these 9,493, 10,463 and 32,176 haplotypes were found in the jumping libraries of AluSx, Alu6b and Alu14b, respectively (Fig. 2; Supplementary Tables 47). These numbers include both high and low jumpers without any further cutoffs. We found that the aforementioned highly enriched SNVs, which likely appeared either due to PCR bias or founder effect during library generation, were not significantly enriched in Alu jumping libraries (with +/−2 log2FC, p-value < 10−5), suggesting that they have a minimal effect on jumping activity (Fig. 2c). Interestingly, we also observed in the in Alu-jumping libraries some fragments (>20–25 Mismatches) that were shorter than 200bp that were missing the right arm monomer (Extended Data Fig. 7), fitting with previous reports that showed that Alu elements missing this arm can still retain jumping activity15. We checked where the reads start (Extended Data Fig. 8) and all these <200bp fragments were clustered at around the same position in the Alu after the left monomer (Extended Data Fig. 7). We confirmed via PCR amplification using Alu recovery primers (Supplementary Table 3) that these short reads are not an artifact due to non-specific amplification from the untransfected HeLa cell genome (Extended Data Fig. 2c). We removed these haplotypes from our subsequent analyses.

Identification of haplotypes that alter Alu jumping potential

We next set out to identify Alu haplotypes that lead to a significant increase in retrotransposition, by measuring differential enrichment in Alu-Mut jumping vs Alu-Mut plasmid libraries (Fig. 2c; Fig. 3ac). For each library, the normalized counts of all haplotypes were calculated using DESeq212. We estimated log2FC by comparing Jumping haplotypes to Plasmid library (Methods) and normalizing to the reference Alu sequence (Fig. 3ac). We applied a cuttoff of Log10P p-value threshold of 10−5 for significant haplotypes and refer to >2 log2FC as high jumpers and <2 log2FC as low jumpers respectively (Fig. 3ac). Haplotypes that were observed in the plasmid library but not in the jumping library, we refer to as non-jumpers. We observed that majority of the unclassified haplotypes that did not fall under any of the above classes (Fig. 3ab) for Alu6b and Alu14b have close to or lower log2FC than their reference sequence signifying their inherent low jumping potential. In contrast, for AluSx, which is inherently active, there were more non-classified haplotypes showed higher log2FC (Fig 3c). We next analyzed the number of nucleotide changes required to obtain jumping activity. We found that a minimum of two changes are needed for Alu6b and five for Alu14b. For AluSx, as it is already an active jumper, we analyzed how many changes are needed to increase its jumping potential, finding that one nucleotide change was sufficient to substantially increase the >2 log2FC (Fig. 3d).

Figure 3: Haplotypes of dominant jumping effects.

Figure 3:

a-c, Violin (left panel) and Volcano (right panel) plots showing fold change differences in high jumpers, low jumpers and possible non-jumping Alu haplotypes with cutoff of +/− 2 log2 fold change (Log2FC) for Alu14B-Mut (a), Alu6B-Mut (b), AluSx-Mut (c), respectively. Significant effects were defined using the DESeq2 package with a Wald-test and p-value threshold of 10-5. Classes were defined as significant high jumpers in red (Log2FC > 2), significant low jumpers in blue (Log2FC < −2, jumping counts > 0) and non-jumpers in purple (Log2FC < −2, jumping counts = 0 and plasmid count > 50). Non-significant haplotypes are shown in grey. Plots are normalized to a zero Log2FC of the reference or wildtype sequence (in green) of each element. d, The number of nucleotide changes observed in the library with respect to the reference or wildtype sequence for high jumper (top) and low/non jumper haplotypes (bottom).

Our assay only detects variants that are present in Alu sequences that jumped but does not detect haplotypes that are either non-jumpers or could be absent due to other reasons that are not related to retrotransposition ability. We thus applied a significantly higher threshold of read counts for potential haplotypes that reduce jumping activity, requiring over 50 reads in the plasmid and zero reads in the jumping library in any of the replicates. This allowed us to separate out potential non-jumpers (Fig. 3ac) from background that could be due to various experimental effects. Combining results of the low and non-jumpers, we found that one nucleotide change for AluSx, two nucleotide changes for Alu6B and seven nucleotide changes for Alu14B were required to decrease or abolish jumping potential (Fig. 3d).

Mutations that affect jumping are associated with SRP binding domains

We next analyzed the dataset along the length of the Alu element to reveal positions or domains where mutations have potential to contribute towards positive or negative jumping activity. We used a 5bp sliding window analysis to score the activity from different nucleotide variants over the sliding window across the full-length of the Alu element (Fig. 4). We fit multiple linear regression models and plot the coefficients reflecting the combined effect of variants over the respective 5bp tiles/windows. Our results indicate that the log2FC haplotype activity presented above correlates well with the 5bp window analysis, which allows us to compensate for the differences in variant density and representation of certain variants from the saturation mutagenesis process.

Figure 4: Mutations that affect jumping are associated with SRP binding domains.

Figure 4:

a-c, In the top panel 5bp-sliding window analyses of Alu6B (a), Alu14b (b), and AluSx (c), are shown along with the Alu-RNA folding structure in the panels below. The folding structure is reverse mountain coded with different colors for each secondary structure: stem loop-unhybridized in teal, hybridized left strand of the stem in dark blue and hybridized right arm of the stem in yellow. The upper right panel show predicted RNA secondary structures with the left SRP and right arm SRP binding folds highlighted in red. The right lower panels show hypergeometric analyses with the enrichment of variants of dominant jumping effect in SRP binding regions (red bar) versus the enrichment of variants of negative jumping effect in SRP binding regions (blue bar). Next to these, sequence logos show DNA nucleotide composition observed in high jumper (top) and low jumper (bottom) haplotypes at select positions.

Alu retrotransposons are transcribed by the RNA PolIII machinery and fold into a specific RNA structure16. This secondary structure of Alu-RNA is crucial to engage the transposition machinery15,17. Alu-RNA has distinct regions in its left half (1-120bp), termed the left arm or monomer, followed by a middle A-stretch and a right arm or monomer (150-300bp) (Fig. 2c). The left and right arms of Alu-RNA fold independently in a series of stems and loops. One of the secondary structures that is formed at the 5’ of each left and right arm is the bipartite stem-loop structure that binds to the signal recognition particle (SRP9/14) complex. The SRP binding site on left arm has annotated BoxA and BoxB regions that are known to be crucial for retrotransposition6,18,19. SRP complex binding is crucial for the process of transposition and nucleotide changes that alter the binding affinity of the SRP complex can affect the transposition efficiency17. The 5bp window analysis clearly indicated an enrichment of activity alteration in the SRP binding domains that correspond to Alu RNA secondary structure.

We used RNAfold to predict the secondary structure of the Alu-RNA20. We analyzed whether nucleotide changes in regions that were predicted to positively affect the haplotype frequency are enriched in the SRP binding stem-loop structure (Fig. 4). We performed a hypergeometric test of variants in high jumpers and low/non jumpers in the SRP binding regions for both left and right SRP binding structures. Interestingly, we observed that variants in the SRP binding stem-loop structures were highly enriched for high jumpers compared to low/non jumpers in all Alu classes tested (Hypergeometric test Alu6b P value=0.00, Alu14b P value=1.65e-05, AluSx P value=0.00) (Fig. 4). We performed sequence analysis on both left and right SRP binding structures to pinpoint changes that are contributing towards Alu jumping potential (Fig. 4, Extended Data Fig 9). We found that individual nucleotide alterations in these regions were sufficient to modify Alu jumping activity. Furthermore, we observed clear differences in the frequency of certain nucleotides at specific positions in high jumping vs low jumping haplotypes. In summary, our results show that nucleotide changes overlapping predicted Alu SRP binding regions have a major effect on transposition.

Comparison to AluS sequences in the human reference genome

We next set out to quantify how many mutations can lead to the activation of AluS elements in the human reference genome. The human genome has around half a million (551,383) copies of AluS elements and around 852 of those have an intact 280bp core4. We extracted AluS elements previously identified from the genome4 and added a custom identifier for each (Supplementary Tables 89). We first aligned our AluS jumping haplotypes to the subset of AluS sequences in the human genome that have an intact 280bp core region, finding that none of these haplotypes have an exact match with these elements. By testing 27 AluS elements individually, it was previously shown that no full length AluS is active in a retrotransposition assay when it is 10% (28 nucleotide changes) divergent from the consensus active AluSx sequence4. We first plotted the total number of haplotype counts generated in the Alu-Mut jumping libraries by the number of mismatches to existing AluS sequences in the human genome with an intact 280bp core (Fig. 5a). From our MPJA study, we found that the closest jumping haplotypes for Alu6B or AluSx are seven mismatches away from endogenous AluS and ten mismatches for Alu14B (Fig. 5ab). Analyzing only the high jumper haplotypes, we found eight mismatch differences for Alu6B or AluSx and twelve mismatches for Alu14B (Fig. 5b). We also looked at how many AluS elements in the human genome could potentially become jumpers upon mismatches. We plotted the number of genomic AluS that have mismatches with only high jumper haplotypes from our mutagenesis library. We found up to fifteen high jumping haplotypes in our library similar to eight distinct Alu elements from the genome that are 8–16 mismatches away from being high jumpers (Fig. 5c).

Figure 5: Comparison of endogenous human genome AluS sequences and Alu MPJA haplotypes.

Figure 5:

a, 852 genomic AluS from the human genome were compared to the haplotypes found in the mutagenized libraries of each element. We detected haplotypes that are at least seven mismatches away from the genomic AluS in AluSx and Alu6B mutagenized libraries and at least eleven mismatches away for Alu14B haplotypes. b, Bar chart showing the mismatch distance of high (top panel) or low (bottom panel) jumpers in the MPJA from genomic AluS sequences. c, Dot plot showing fifteen identified AluS elements from the human genome (Supplementary Table 8) that require minimum number of nucleotide changes to match with the high jumper haplotypes.

Discussion

Retrotransposition of genomic elements is a major force driving genomic diversity1. Around 11% of the human genome consists of Alu retrotransposons with 1.4 million copies existing in various genomic locations. With a germline mutation rate of 1.2 × 10−8 per base pair per generation2123, the sequences of many Alus can change over time, which could potentially lead to their reactivation. Most Alu elements are inactive due to sequence disintegration, but a few have maintained sequence features necessary for jumping, i.e., an intact 280bp core sequence with BoxA and BoxB in the left monomer as well as a PolyA tail6. It is unknown how nucleotide changes present throughout the Alu elements may affect their jumping potential. The assays developed so far measure the activity of an individual transposon precluding our ability to identify nucleotide changes at a higher resolution level that could affect their jumping potential. To address this, we developed an assay that can test in a high-throughput manner the jumping capability of thousands of sequences. We used four different AluS elements, constructing libraries containing 167,534 unique haplotypes and tested their jumping ability. This assay could be easily modified for other Alu families, for example the AluY family that is still active in the human genome, as well as other types of retrotransposons.

We found that it takes a minimum of one for AluSx, two for Alu6B and five for Alu14B nucleotide changes to increase the jumping potential, most of them residing in SRP binding domains. Here, we limited our analysis to ten mismatches, thus limiting our ability to observe effects for more sequence alterations. To overcome limitations of the error-prone PCR step, a synthetic design of the Alu library (e.g., by oligosynthesis) could incorporate widespread changes including larger deletions or insertions. In addition, designed Alu sequences could potentially also test for variant combination effects, i.e. analyzing numerous variant combinations to identify how they interact and affect each other.

There are several critical steps that can affect Alu retrotransposition. The Alu-RNA with 3’polyA tail folds and forms the secondary structure crucial for binding of SRP9/14 complexes. There is one SRP9/14 binding site in each arm of the Alu RNA. This ribonucleoprotein complex recruits L1-ORF2 machinery that has reverse-transcriptase and transposon complex and randomly integrates into the genome. Any disruption during this process can lead to abrogation of the jumping potential9. In our dataset, non-jumpers could have mutations that disrupt any of the following processes: 1) Transcription of the Alu element via RNA Polymerase III; 2) polyA tailing; 3) misfolding of Alu-RNA; 4) poor binding of the SRP9/14 complex; 5) inability to recruit the L1-ORF2 machinery. As this assay is primarily designed to identify jumping activity, it is limited in identifying variants that inhibit jumping. Despite that, using stringent conditions, we did detect a small number of variants that abolished jumping, although with lower confidence. Further studies will be required to parse out these other retrotransposition associated factors in a systematic manner.

We observed a spike in fragments that have >20–25 mismatches only in jumping libraries and not in plasmid libraries. We think this could be due to the inherent nature of our assay system/cells. Since we do not know how Alu RNA is processed in these cells, we filtered these fragments from our analyses. However, alternative cells or assay systems may not show this high mismatch number and/or provide an understanding of its cause. Surprisingly, we also observed a small proportion of fragments to be smaller than 200 nucleotides in length in both our jumping libraries and Alu-mut plasmid libraries, that could not be explained based on how we processed these sequencing libraries. Of note, it has been reported earlier that the minimal Alu RNA length required for jumping could be less than 200 bp and devoid of its right arm monomer15, fitting with our finding. Here, we removed these sequences from our analysis, but future MPJA could be used to test what are the critical Alu sequences in this left arm monomer that allow it to jump.

MPJA could also be applied to investigate whether Alu activity could potentially be involved in evolutionary adaptations or human disease by testing specific somatic mutation haplotypes detected in patients. The haplotype data that we generated could be compared with patient data such as whole genome sequences from cancer patients, to elucidate if any observed mutations in Alu sequences could lead to its reactivation or retrotransposition and consequently increase genomic mutation frequencies. It is also important to consider that Alu elements need an active L1 to provide the retrotransposition machinery, as they are non-autonomous jumpers. L1 is active during germline development, early embryonic development, cancer progression or in neurodegenerative diseases which could affect Alu retrotransposition if inherently active Alu elements are present in the genome2431. A previous study that individually examined the retrotransposition ability of several AluS, estimated that at least 28 nucleotide changes (10% variation) from the consensus active sequence AluSx are needed to obtain jumping activity4. Here, we found that this number can be much lower, with up to seven mismatches for some of the AluS subclasses. We focused on the AluS family for our study, but future studies could be easily extended to other classes of Alu elements in the human genome, for example the youngest AluY family elements that are currently active in the genome and have even higher potential to be involved in human disease.

In summary, we provide a novel high-throughput approach to test the jumping activity of thousands of Alu retrotransposons in parallel that could be adopted for other retrotransposons including DNA transposons. This could facilitate the studies of jumping elements en masse in different conditions and be used to address various biological questions related to transposons.

Materials and methods

Retrotransposition assay

The Alu retrotransposition assay was performed as previously described4,5,9. Briefly, HeLa cells (a kind gift from Dr. Astrid Engel, Tulane University) were transfected with lipofectamine LTX reagent using pYa5-neo and pL1-ORF2 or L1 helper (kind gift from Dr. Astrid Engel, Tulane University) at a 1:1 concentration ratio. After 72 hours, DMEM with G-418 (500ug/ml) and pen-strep (100ug/ml) was replaced and the neomycin selection medium was refreshed every 72 hrs for 2–3 weeks. Colonies were washed with PBS and stained with 0.5% Crystal Violet staining solution containing 10% ethanol and 50% methanol.

Error prone PCR and Alu library cloning

AluSx, Alu14B, Alu6B and Aluh1.1 were synthesized as gene blocks (IDT) and cloned into BamHI-AatII sites in the pYa5-neo vector using Infusion cloning kit (Takara) following the manufacturer’s protocol. To generate mutagenized libraries with error-prone PCR, we used the GeneMorphII random mutagenesis kit (Agilent) following the manufacturer’s protocol. Two independent reactions with 10ng of plasmid subjected to 25 PCR cycles were pooled and cleaned using the PCR clean up kit (Qiagen; 28104). The mutagenesis primer (Supplementary Table 1) towards the 3’ of the Alu matches the last base in the vector and therefore the 3’ of Alu was subjected to random mutagenesis. To facilitate subsequent resurrection and retrieval of the jumping Alu haplotypes from the genome, mutagenesis was initiated only after the first 27 bases into the 5’ end of the Alu. This allowed us to specifically resurrect the retrotransposed and integrated Alu-Neo cassette from the genome via nested PCR amplification strategy (Fig. 1c). Mutagenesis primers had 15bp overhangs at either side to aid Infusion cloning into PstI-AatII sites of the pYa5-neo vector. Four independent Infusion-cloning reactions were set up and transformed into four different vials of 150ul each of Stellar competent bacterial cells. Each recovered competent cell vial was used as inoculum for 75ml of LB broth which was cultured overnight. Four different plasmid midi preps (Midi prep kit; Qiagen) were pooled to obtain the Alu-Mut library. This procedure was performed separately for each Alu element.

Jumping Alu-Mut library retrieval

MPJA was performed on 15cm cell culture dishes (Corning). After stable selection for 3–4 weeks on G418, colonies were scrapped from plate for genomic DNA isolation using genomic DNA isolation kit (Promega). The spliced and retrotransposed Alu-Neo cassette (1kb) was isolated from genomic DNA using Alu recovery and resurrection primers described in Supplementary Table 3. This primer set (PCR-a) allowed to differentiate between the randomly integrated unspliced plasmid DNA product which is 1.5kb in length. The 1kb PCR fragment was then used for nested PCR-b using primers described in Supplementary Table 3. Plasmid mutagenesis libraries were prepared by using PCR-b on the mutagenized plasmid library as the template directly. The amplicon library was then prepped as described above using the Ovation low complexity kit. Libraries were sequenced on Illumina MiSeq with Paired End (PE) 250bp reads and multiple runs.

Library sequencing and analysis

Alu-Mut plasmid libraries were generated using PCR-based amplification with primers sets described in Supplementary Table 3 using the Ovation low complexity library prep kit (Ovation® Library system for Low complexity samples Part no: 9092–16). Briefly, the PCR amplicon was end-repaired, and forward and reverse diversity adaptors were ligated, filled-in and dual index barcode i5 and i7 primers were used to perform PCR for 10 cycles to generate the Alu library fragments (Supplementary Table 10). Libraries were sequenced on Illumina MiSeq with multiple PE 250bp runs. PE reads were processed and stitched together to full-length fragments with PEAR32 and aligned with BWA33 to Alu reference sequences. Custom scripts were used in the analysis for variant calling and filtering. We identified unique haplotypes based on the alignment information stored in BAM format, specifically we used position and CIGAR fields as well as MD (differences to the aligned reference sequence) and NM (alignment edit distance) tags to identify identical haplotypes and to count their abundance. The edit distance in the NM field was used to filter and to report the minimum number of required edits to the reference sequence. We performed differential activity analysis using DESeq212 on unique haplotypes.

High, low, non-jumper definitions

For all haplotype variants, we compared the fragment counts from two jumping replicates and two plasmid replicates. We use DESeq212 to define high jumpers (log2 fold-change > 2, p-value < 10−5), low jumpers (log2 fold-change < −2, p-value < 10−5, jumping counts > 0) and non-jumpers (log2 Fold change < −2, p-value < 10−5, jumping counts = 0, plasmid counts > 50).

Inferring variant level activity effects

To infer the activity effects of individual variants along the different Alu elements, we considered every variant (including deletion and insertion) along all haplotypes of a specific experiment. These were included in a matrix with the haplotypes as rows including their plasmid count, jumping count, and N binary columns indicating whether specific variants were associated with that haplotype. We then fit a combined multiple linear regression model of both replicates10 (Equation 1).

log2Jumpingi,jlog2Plasmidrep1,jVi=10Velse+log2Plasmidrep2,jVi=20Velse+N+offset (1)

Inferring sliding-window activity effects

To infer the regional activity effects along the different Alu elements, we applied a 5bp sliding-window approach where we use 5bp windows with an offset of 1 bp along the length of the Alu elements. We considered every variant (including deletion and insertion) in each window and considered the combined plasmid count and jumping counts for the center of the window. We then fit a combined multiple linear regression model of both replicates10.

Sequence analysis and logos

We analyzed the frequency of nucleotides in short sequence regions, i.e. motifs, by contrasting haplotypes of high and low jumping activity. For both SRP binding regions (left arm and right arm in each element), we generated logo plots (ggseqlogo R package34) with input of SRP left and right binding regions respectively.

Hypergeometric test for SRP binding enrichment

To determine whether variants in SRP binding regions are overrepresented or underrepresented in high, low or non-jumpers, we took the total variants from all Alu elements (including all haplotypes) as background. Similar to the gene set enrichment analysis, a significant p-value obtained from the hypergeometric test suggested that the variants in SRP binding regions are enriched in high jumpers, whereas a non-significant p-value suggested that variants in SRP binding regions are not enriched in low or non-jumpers. The p-value was adjusted for multiple testing to control the false discovery rate (Benjamini Hochberg correction).

RNA structure prediction

We used the RNAfold webserver20 to predict the secondary structures of single stranded RNA sequences, for which we first converted Alu DNA sequences to RNA. We manually set folding constraints to obtain an Alu-like structure, i.e. we are not just reporting the minimum free energy structures, but an Alu RNA like structure that requires secondary structure folding of left arm monomer and right arm monomer separately with unstructured middle A stretch.

Supplementary Material

Supplement 1
media-1.pdf (38.8MB, pdf)

Acknowledgments:

This work was supported in part by the National Human Genome Research Institute (NHGRI) grant numbers UM1HG009408 (NA) and UM1HG011966 (MK, NA) and National Institute of General Medical Sciences R01GM142112 (NA), Innovative Genomics Institute, IGI-RIDER and IGI-WIES funding (NM). We thank Astrid Engel for providing valuable guidance for retrotransposition assays and sharing vectors and HeLa cell line.

Data availability

All sequencing data for this study has been deposited in the GEO database under accession code PRJNA1098913.

References

  • 1.Cordaux R. & Batzer M. A. The impact of retrotransposons on human genome evolution. Nature Reviews Genetics vol. 10 Preprint at 10.1038/nrg2640 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Cordaux R., Hedges D. J., Herke S. W. & Batzer M. A. Estimating the retrotransposition rate of human Alu elements. Gene 373, (2006). [DOI] [PubMed] [Google Scholar]
  • 3.Deininger P. Alu elements: Know the SINEs. Genome Biology vol. 12 Preprint at 10.1186/gb-2011-12-12-236 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Bennett E. A. et al. Active Alu retrotransposons in the human genome. Genome Res 18, (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Dewannieux M. & Heidmann T. Role of poly(A) tail length in Alu retrotransposition. Genomics 86, (2005). [DOI] [PubMed] [Google Scholar]
  • 6.Roy-Engel A. M. et al. Non-traditional Alu evolution and primate genomic diversity. J Mol Biol 316, (2002). [DOI] [PubMed] [Google Scholar]
  • 7.Kopera H. C. et al. LEAP: L1 element amplification protocol. in Methods in Molecular Biology vol. 1400 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Streva V. A. et al. Sequencing, identification and mapping of primed L1 elements (SIMPLE) reveals significant variation in full length L1 elements between individuals. BMC Genomics 16, (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Dewannieux M., Esnault C. & Heidmann T. LINE-mediated retrotransposition of marked Alu sequences. Nat Genet 35, (2003). [DOI] [PubMed] [Google Scholar]
  • 10.Kircher M. et al. Saturation mutagenesis of twenty disease-associated regulatory elements at single base-pair resolution. Nat Commun 10, (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Lee S. O. & Fried S. D. An error prone PCR method for small amplicons. Anal Biochem 628, (2021). [DOI] [PubMed] [Google Scholar]
  • 12.Love M. I., Huber W. & Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15, (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Illumina. Effects of Index Misassignment on Multiplexing and Downstream Analysis. Illumina (2017) doi: 10.1101/125724. [DOI] [Google Scholar]
  • 14.Kircher M., Sawyer S. & Meyer M. Double indexing overcomes inaccuracies in multiplex sequencing on the Illumina platform. Nucleic Acids Res 40, (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Ahl V., Keller H., Schmidt S. & Weichenrieder O. Retrotransposition and Crystal Structure of an Alu RNP in the Ribosome-Stalling Conformation. Mol Cell 60, (2015). [DOI] [PubMed] [Google Scholar]
  • 16.Huck L. et al. Conserved tertiary base pairing ensures proper RNA folding and efficient assembly of the signal recognition particle Alu domain. Nucleic Acids Res 32, (2004). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Weichenrieder O., Wild K., Strub K. & Cusack S. Structure and assembly of the Alu domain of the mammalian signal recognition particle. Nature 408, (2000). [DOI] [PubMed] [Google Scholar]
  • 18.Häsler J. & Strub K. Alu elements as regulators of gene expression. Nucleic Acids Res 34, (2006). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Conti A. et al. Identification of RNA polymerase III-transcribed Alu loci by computational screening of RNA-Seq data. Nucleic Acids Res 43, (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Gruber A. R., Lorenz R., Bernhart S. H., Neuböck R. & Hofacker I. L. The Vienna RNA websuite. Nucleic Acids Res 36, (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Campbell C. D. & Eichler E. E. Properties and rates of germline mutations in humans. Trends in Genetics vol. 29 Preprint at 10.1016/j.tig.2013.04.005 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Kong A. et al. Rate of de novo mutations, father’s age, and disease risk. Nature 488, (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Conrad D. F. et al. Variation in genome-wide mutation rates within and between human families. in Nature Genetics vol. 43 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.DiRusso J. A. & Clark A. T. Transposable elements in early human embryo development and embryo models. Current Opinion in Genetics and Development vol. 81 Preprint at 10.1016/j.gde.2023.102086 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.González-Rico F. J. et al. Alu retrotransposons modulate Nanog expression through dynamic changes in regional chromatin conformation via aryl hydrocarbon receptor. Epigenetics Chromatin 13, (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Larsen P. A. et al. The Alu neurodegeneration hypothesis: A primate-specific mechanism for neuronal transcription noise, mitochondrial dysfunction, and manifestation of neurodegenerative disease. Alzheimer’s and Dementia vol. 13 Preprint at 10.1016/j.jalz.2017.01.017 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Polesskaya O. et al. The role of Alu-derived RNAs in Alzheimer’s and other neurodegenerative conditions. Med Hypotheses 115, (2018). [DOI] [PubMed] [Google Scholar]
  • 28.Larsen P. A., Hunnicutt K. E., Larsen R. J., Yoder A. D. & Saunders A. M. Warning SINEs: Alu elements, evolution of the human brain, and the spectrum of neurological disease. Chromosome Research 26, (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Di Ruocco F. et al. Alu RNA accumulation induces epithelial-to-mesenchymal transition by modulating miR-566 and is associated with cancer progression. Oncogene 37, (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Tang R. B. et al. Increased level of polymerase III transcribed Alu RNA in hepatocellular carcinoma tissue. Mol Carcinog 42, (2005). [DOI] [PubMed] [Google Scholar]
  • 31.Hwang T. et al. Genome-wide perturbations of Alu expression and Alu-associated post-transcriptional regulations distinguish oligodendroglioma from other gliomas. Commun Biol 5, (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Zhang J., Kobert K., Flouri T. & Stamatakis A. PEAR: A fast and accurate Illumina Paired-End reAd mergeR. Bioinformatics 30, (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Li H. & Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Wagih O. Ggseqlogo: A versatile R package for drawing sequence logos. Bioinformatics 33, (2017). [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplement 1
media-1.pdf (38.8MB, pdf)

Data Availability Statement

All sequencing data for this study has been deposited in the GEO database under accession code PRJNA1098913.


Articles from bioRxiv are provided here courtesy of Cold Spring Harbor Laboratory Preprints

RESOURCES